Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
- 14 June 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 7 (2), 316-326
- https://doi.org/10.1007/s12072-011-9279-6
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerJournal of Viral Hepatitis, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximabThe Esophagus, 2008
- A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trialHepatology, 2007
- Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patientsBreast Cancer Research and Treatment, 2004
- Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinomaJournal of Hepatology, 2004
- Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantationBone Marrow Transplantation, 2004
- Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramersImmunology Letters, 2004
- Persistence of hepatitis B virus DNA after serological clearance of hepatitis B virusLiver International, 1990